...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >FORMULATION AND EVALUATION OF HERBAL ANTIDEMENTIAL TABLETS
【24h】

FORMULATION AND EVALUATION OF HERBAL ANTIDEMENTIAL TABLETS

机译:草药抗炎药的配方和评价

获取原文

摘要

Herbs and their extracts/fractions are used for the treatment of different diseases and few as a memory enhancing agent. Different plants have been used as a memory enhancer in the folkloric medicine. Present study was undertaken to prepare a combined herbal formulation of the extracts of dried root powder of Plumbagozeylanica and powdered seeds of Silybummarianum for the treatment of dementia. HPTLC quantification characterization and identification of the herbal extracts of P. zeylanica and S. marianum, was performed using the standard marker compound, plumbagin and silibinin respectively of these drugs. Through the acute oral toxicity studies the dose of the extract in the formulation and a LD50 and ED50 profile of the drug combination were established. Design & development of tablet using two doses of the extract was done and evaluation was carried out on various standard parameters of formulation including accelerated stability tests, which was in turn found satisfactory and within the specified limits. Preliminary pharmacological screening of dementia was performed on formulated tablets using EPM (Elevated plus maze) and MWM (Morris water maze), two of the animal models of dementia. Here, Piracetam (400mg/kg p.o) a nootropic agent was employed as a standard drug. Sodium Nitrite (75mg/kg i.p) was used to induce amnesia in young experimental model, and which is comparable with that of the age related amnesia in old rats. The results indicate that administration of tablets produce significant dose dependant improvement of memory and were almost similar with that of standard drug Piracetam. In the present study antidemential activity of the combined herbal formulation of P. zeylanica and S. marianum and a few standardization parameters were tried to established, which can be further analysed and proceeded to prepare an effective antidemential formulation.
机译:草药及其提取物/级分用于治疗各种疾病,很少用作记忆增强剂。不同的植物已被用作民俗医学中的记忆增强剂。进行本研究以制备组合的草药制剂,该草药制剂由Plumbagozeylanica的干燥根粉和水飞蓟粉的种子提取物制成,用于治疗痴呆。分别使用标准标记化合物,plumbagin和silibinin对这两种药物进行的HPTLC定量表征和鉴定P. zeylanica和S. marianum的草药提取物。通过急性口服毒性研究,确定了制剂中提取物的剂量以及药物组合的LD50和ED50特性。使用两次剂量的提取物进行了片剂的设计和开发,并对包括加速稳定性测试在内的各种标准配方参数进行了评估,结果发现令人满意并在规定的范围内。痴呆症的初步药理学筛选是使用两种痴呆动物模型EPM(高架迷宫)和MWM(莫里斯水迷宫)对制成的片剂进行的。在此,将吡拉西坦(400mg / kg p.o)促智剂用作标准药物。亚硝酸钠(75mg / kg i.p)在年轻的实验模型中用于诱发健忘症,与老年大鼠的年龄相关性健忘症相当。结果表明片剂的给药产生显着的剂量依赖性记忆改善,并且与标准药物吡拉西坦几乎相似。在本研究中,尝试建立了P. zeylanica和S. marianum的组合草药制剂的抗痴呆活性,并建立了一些标准化参数,可以对其进行进一步的分析和制备一种有效的抗痴呆制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号